Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui Lv

Showing results (511-520 of 522) with videos related to

Pageof 53
Sort By:
Endocrine Journal|December 28, 2017
Whole-genome sequencing revealed armadillo repeat containing 5 (ARMC5) mutation in a Chinese family with ACTH-independent macronodular adrenal hyperplasiaQian Zhang, Liang Cui, Jiang-Ping Gao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2020
MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of itWang-Zhong Li, Guo-Ying Liu, Lan-Feng Lin, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2015
Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patientsWei-Jun Gu, Qian Zhang, Ying-Qian Wang, et al.
Frontiers in Oncology|October 20, 2025
Time to recurrence and BCLC stage at recurrence as critical variables in guiding treatment decisions for early-recurrent hepatocellular carcinoma after liver resectionJian-Xi Zhang, Luo-Bin Guo, Chong-Shi Zeng, et al.
ACS Nano|March 29, 2022
Correction to "A DNA Nanoraft-Based Cytokine Delivery Platform for Alleviation of Acute Kidney Injury"Wei Li, Chengshi Wang, Hui Lv, et al.
ACS Nano|November 1, 2021
A DNA Nanoraft-Based Cytokine Delivery Platform for Alleviation of Acute Kidney InjuryWei Li, Chengshi Wang, Hui Lv, et al.
Journal of Cancer|September 14, 2018
Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-upQin Yang, Ting-Ting Zhao, Meng-Yun Qiang, et al.
Cancer Cell|August 6, 2019
A Pharmacogenomic Landscape in Human Liver CancersZhixin Qiu, Hong Li, Zhengtao Zhang, et al.
Genomics, Proteomics & Bioinformatics|June 11, 2024
A Two-color Single-molecule Sequencing Platform and Its Clinical ApplicationsFang Chen, Bin Liu, Meirong Chen, et al.
The Lancet. Oncology|April 15, 2021
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trialXing Lv, Xun Cao, Wei-Xiong Xia, et al.
Pageof 53

Showing results (511-520 of 522) with videos related to

Sort By:
Pageof 53
Endocrine Journal|December 28, 2017
Whole-genome sequencing revealed armadillo repeat containing 5 (ARMC5) mutation in a Chinese family with ACTH-independent macronodular adrenal hyperplasiaQian Zhang, Liang Cui, Jiang-Ping Gao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2020
MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of itWang-Zhong Li, Guo-Ying Liu, Lan-Feng Lin, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2015
Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patientsWei-Jun Gu, Qian Zhang, Ying-Qian Wang, et al.
Frontiers in Oncology|October 20, 2025
Time to recurrence and BCLC stage at recurrence as critical variables in guiding treatment decisions for early-recurrent hepatocellular carcinoma after liver resectionJian-Xi Zhang, Luo-Bin Guo, Chong-Shi Zeng, et al.
ACS Nano|March 29, 2022
Correction to "A DNA Nanoraft-Based Cytokine Delivery Platform for Alleviation of Acute Kidney Injury"Wei Li, Chengshi Wang, Hui Lv, et al.
ACS Nano|November 1, 2021
A DNA Nanoraft-Based Cytokine Delivery Platform for Alleviation of Acute Kidney InjuryWei Li, Chengshi Wang, Hui Lv, et al.
Journal of Cancer|September 14, 2018
Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-upQin Yang, Ting-Ting Zhao, Meng-Yun Qiang, et al.
Cancer Cell|August 6, 2019
A Pharmacogenomic Landscape in Human Liver CancersZhixin Qiu, Hong Li, Zhengtao Zhang, et al.
Genomics, Proteomics & Bioinformatics|June 11, 2024
A Two-color Single-molecule Sequencing Platform and Its Clinical ApplicationsFang Chen, Bin Liu, Meirong Chen, et al.
The Lancet. Oncology|April 15, 2021
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trialXing Lv, Xun Cao, Wei-Xiong Xia, et al.
Pageof 53